EUVIMEDEUVIMED entdecken
Crossref

Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer

歆睿 张

Pharmacy Information · 2026 · 15 (06) · 530-537

DOI: 10.12677/pi.2026.156056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy Information, 2026. Verfasst von 歆睿 张. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

张, 歆. (2026). Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer. Pharmacy Information, 15(06), 530-537. https://doi.org/10.12677/pi.2026.156056

Vancouver

张 歆. Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer. Pharmacy Information. 2026;15(06):530-537. doi:10.12677/pi.2026.156056

BibTeX
@article{2026,
  author = {张, 歆睿},
  title = {Advances in the Efficacy of Novel Targeted Therapeutics for HR+/HER2- Breast Cancer},
  journal = {Pharmacy Information},
  year = {2026},
  volume = {15},
  number = {06},
  pages = {530--537},
  doi = {10.12677/pi.2026.156056}
}
Kostenlos starten →